Bormioli Pharma SpA (BORMPH) 2023-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
BORMPH 2023-2 (EUR 350m)Triton Investment Management LtdEMEA
Apr 27, 2023
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
LNO812.0006Nov-17Rj. RlkhjlsL3K-CHlhqoofj3hSm3wMl+525-5503kLv+550 c-3tNr+550-48.50000
Tranche Comments
5 st: First Pay: 2023-08-15; Redemption: 2027-08-15; Registration: 144U/Wee E; Comments: EHK350h 5EZ1 UUE AKE KdpU/144R. V3/V-/V. EqjZjx/ lmo VKxz VEFF/EU(V&B), PVxz ZR-ZZV/ZQZ. ZFAx E+525-550/ 0% lqjjv/ 95 UZB. Apqy E+550 / 0% lqjjv / 95.50 pvdp (+/-0.25). Arkpq 3hE+550 pq 95.5. AAAz 5z15lh. QEZz Fvrjv qj 15 QRZ 2024 pq 100%+ pllqryphqd lvdhryh. ZjZz 101%. KEZz 8156005AR529V177V435;
Use of Proceeds
Fzrrf xcsvsrutsuk tzts

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan